These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26350215)

  • 21. The dark side of E2F1: in transit beyond apoptosis.
    Engelmann D; Pützer BM
    Cancer Res; 2012 Feb; 72(3):571-5. PubMed ID: 22298593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
    Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
    Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel role of PELP1 in regulating chemotherapy response in mutant p53-expressing triple negative breast cancer cells.
    Krishnan SR; Nair BC; Sareddy GR; Roy SS; Natarajan M; Suzuki T; Peng Y; Raj G; Vadlamudi RK
    Breast Cancer Res Treat; 2015 Apr; 150(3):487-99. PubMed ID: 25788226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
    Ofir M; Hacohen D; Ginsberg D
    Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
    Cassimere EK; Pyndiah S; Sakamuro D
    Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress.
    Lezina L; Aksenova V; Ivanova T; Purmessur N; Antonov AV; Tentler D; Fedorova O; Garabadgiu AV; Talianidis I; Melino G; Barlev NA
    Cell Death Differ; 2014 Dec; 21(12):1889-99. PubMed ID: 25124555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of E2F1 function by the nuclear corepressor KAP1.
    Wang C; Rauscher FJ; Cress WD; Chen J
    J Biol Chem; 2007 Oct; 282(41):29902-9. PubMed ID: 17704056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
    Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
    Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The E2F1-miRNA cancer progression network.
    Knoll S; Emmrich S; Pützer BM
    Adv Exp Med Biol; 2013; 774():135-47. PubMed ID: 23377972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.
    Wang C; Chen L; Hou X; Li Z; Kabra N; Ma Y; Nemoto S; Finkel T; Gu W; Cress WD; Chen J
    Nat Cell Biol; 2006 Sep; 8(9):1025-31. PubMed ID: 16892051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
    Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural diterpene ent-16β-17α-dihydroxykaurane down-regulates Bcl-2 by disruption of the Ap-2α/Rb transcription activating complex and induces E2F1 up-regulation in MCF-7 cells.
    Morales A; Alvarez A; Arvelo F; Suárez AI; Compagnone RS; Galindo-Castro I
    Apoptosis; 2011 Dec; 16(12):1245-52. PubMed ID: 21850486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
    EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of RHAMM with E2F1 promotes tumour cell extravasation by transcriptional up-regulation of fibronectin.
    Meier C; Spitschak A; Abshagen K; Gupta S; Mor JM; Wolkenhauer O; Haier J; Vollmar B; Alla V; Pützer BM
    J Pathol; 2014 Nov; 234(3):351-64. PubMed ID: 25042645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of E2F1 during ER stress is required to induce apoptosis.
    Pagliarini V; Giglio P; Bernardoni P; De Zio D; Fimia GM; Piacentini M; Corazzari M
    J Cell Sci; 2015 Mar; 128(6):1166-79. PubMed ID: 25616897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways.
    Choi D; Lee SJ; Hong S; Kim IH; Kang S
    Oncogene; 2008 Mar; 27(12):1716-25. PubMed ID: 17873902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative Analysis Reveals the Transcriptional Collaboration between EZH2 and E2F1 in the Regulation of Cancer-Related Gene Expression.
    Xu H; Xu K; He HH; Zang C; Chen CH; Chen Y; Qin Q; Wang S; Wang C; Hu S; Li F; Long H; Brown M; Liu XS
    Mol Cancer Res; 2016 Feb; 14(2):163-172. PubMed ID: 26659825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
    Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
    J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the MDR1 promoter by E2F1 and EAPP.
    Andorfer P; Rotheneder H
    FEBS Lett; 2013 May; 587(10):1504-9. PubMed ID: 23542036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.